CN Patent

CN112851664B — 吡唑[1,5-a]吡啶-3-腈化合物及其在医药上的用途

Assigned to Zhejiang Hisun Pharmaceutical Co Ltd · Expires 2024-03-29 · 2y expired

What this patent protects

本发明提供了一种式(I)所示的化合物或其药学上可接受的盐、及其制备方法，以及它们作为治疗剂，特别是作为选择性转染期间重排(RET)激酶抑制剂的用途，其中式(I)中的各取代基的定义与说明书中的定义相同。

USPTO Abstract

本发明提供了一种式(I)所示的化合物或其药学上可接受的盐、及其制备方法，以及它们作为治疗剂，特别是作为选择性转染期间重排(RET)激酶抑制剂的用途，其中式(I)中的各取代基的定义与说明书中的定义相同。

Drugs covered by this patent

Patent Metadata

Patent number
CN112851664B
Jurisdiction
CN
Classification
—
Expires
2024-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Hisun Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.